218 related articles for article (PubMed ID: 17253547)
21. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
[TBL] [Abstract][Full Text] [Related]
22. Protective Effects of Vitamin E on Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Randomized Controlled Trials.
Miao H; Li R; Chen D; Hu J; Chen Y; Xu C; Wen Z
Ann Nutr Metab; 2021; 77(3):127-137. PubMed ID: 34148036
[TBL] [Abstract][Full Text] [Related]
23. The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial.
van Gerven JM; Hovestadt A; Moll JW; Rodenburg CJ; Splinter TA; van Oosterom AT; Keizer L; Drogendijk TE; Groenhout CM; Vecht CJ
J Neurol; 1994 Jun; 241(7):432-5. PubMed ID: 7931444
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.
Duval M; Daniel SJ
J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):309-15. PubMed ID: 23092832
[TBL] [Abstract][Full Text] [Related]
25. Vitamin B for treating peripheral neuropathy.
Ang CD; Alviar MJ; Dans AL; Bautista-Velez GG; Villaruz-Sulit MV; Tan JJ; Co HU; Bautista MR; Roxas AA
Cochrane Database Syst Rev; 2008 Jul; (3):CD004573. PubMed ID: 18646107
[TBL] [Abstract][Full Text] [Related]
26. Rehabilitation following carpal tunnel release.
Peters S; Page MJ; Coppieters MW; Ross M; Johnston V
Cochrane Database Syst Rev; 2013 Jun; (6):CD004158. PubMed ID: 23740605
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity.
Gandara DR; Perez EA; Weibe V; De Gregorio MW
Semin Oncol; 1991 Feb; 18(1 Suppl 3):49-55. PubMed ID: 1848372
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group.
Hilpert F; Stähle A; Tomé O; Burges A; Rossner D; Späthe K; Heilmann V; Richter B; du Bois A;
Support Care Cancer; 2005 Oct; 13(10):797-805. PubMed ID: 16025262
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.
Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
Support Care Cancer; 2006 Nov; 14(11):1134-40. PubMed ID: 16622646
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
[TBL] [Abstract][Full Text] [Related]
31. ACTH/MSH like peptides in the treatment of cisplatin neuropathy.
Gispen WH; Hamers FP; Vecht CJ; Jennekens FG; Neyt JP
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):179-83. PubMed ID: 1326318
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
33. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
[TBL] [Abstract][Full Text] [Related]
34. Chinese herbal medicine for diabetic peripheral neuropathy.
Chen W; Zhang Y; Liu JP
Cochrane Database Syst Rev; 2011 Jun; (6):CD007796. PubMed ID: 21678369
[TBL] [Abstract][Full Text] [Related]
35. Conjunctival autograft for pterygium.
Clearfield E; Muthappan V; Wang X; Kuo IC
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroids for treating nerve damage in leprosy.
Van Veen NH; Nicholls PG; Smith WC; Richardus JH
Cochrane Database Syst Rev; 2007 Apr; (2):CD005491. PubMed ID: 17443594
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
38. Drug treatment for spinal muscular atrophy type I.
Wadman RI; Bosboom WM; van den Berg LH; Wokke JH; Iannaccone ST; Vrancken AF
Cochrane Database Syst Rev; 2011 Dec; (12):CD006281. PubMed ID: 22161399
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive treatment for non-systemic vasculitic neuropathy.
Vrancken AF; Hughes RA; Said G; Wokke JH; Notermans NC
Cochrane Database Syst Rev; 2007 Jan; (1):CD006050. PubMed ID: 17253577
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of vitamin E on chemotherapy-induced peripheral neuropathy: a meta-analysis of randomized controlled trials.
Eum S; Choi HD; Chang MJ; Choi HC; Ko YJ; Ahn JS; Shin WG; Lee JY
Int J Vitam Nutr Res; 2013; 83(2):101-11. PubMed ID: 24491883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
